More Transparency Into Why You Can Trust Our Research

As part of our ongoing efforts to be as transparent as possible, we’d like to draw your attention to three new pages that provide greater insight into New Constructs.

Continue Reading →

Dividend Yield Now Included in My Portfolio, Stock Screeners, and Company Valuation Models

Members now get access to the current dividend yield in our valuation models. They can also sort and screen by current dividend yield in our stock screeners and on the My Portfolio page.

Continue Reading →

Making New Constructs Easy to Enjoy

We strive to make our research as easy to use as possible. To that end, here are multiple new support offerings.

Continue Reading →

Interactive Brokers Integrates with New Constructs


New Constructs is proud to announce our new relationship with Interactive Brokers, an automated global electronic broker that specializes in catering to financial professionals.

Continue Reading →

“Stocks to Buy Regardless of Election” – Barron’s


On Saturday (6/29/16), Barron’s featured our research for the eighth time in 2016 and 24th time since 2014.

Continue Reading →

“Trying To Put the Non-GAAP Genie Back in the Bottle”


On Thursday, Michael Rapoport of The Wall Street Journal interviewed CEO David Trainer regarding the proliferation of non-GAAP earnings and the SEC’s increased efforts to investigate misuse of non-GAAP metrics.

Continue Reading →

Scottrade Membership Video Tour

This video shows how to access and get the most out of New Constructs through Scottrade.

Continue Reading →

Thomson ONE Offers Direct Access to Our Website

This video shows how to access and get the most out of New Constructs on the Thomson ONE workstation

Continue Reading →

“New Constructs Snags Distribution Deals With Big Names”

On Tuesday (9/27/16), Geert De Lombaerde of Nashville Post featured our recent partnerships with firms such as Scottrade and Thomson Reuters.

Continue Reading →

The Fed Is Irrelevant: Low Interest Rates Are the New Normal


It’s time to consider a new paradigm for interest rates – a paradigm where treasury rates remain ultra low and riskier investments are priced by a decentralized market instead of a central bank.

Continue Reading →

“Scottrade Offers Investors New Constructs Research” – Barron’s


On Saturday, Barron’s featured New Constructs’ recent partnership with Scottrade.

Continue Reading →

Thomson Reuters Bolsters Wealth Management Offerings with New Constructs


New Constructs is proud to announce our new relationship with Thomson Reuters, the world’s leading source of news and information for professional markets.

Continue Reading →

Integrity Research Features Success of Our Scottrade Partnership

Integrity Research, advisor to the world’s largest investment managers, featured Scottrade clients’ rapid adoption of New Constructs’ research. Here are key highlights of the Integrity report

Continue Reading →

Scottrade Ramps Up Investment Research With New Constructs Offerings


New Constructs is proud to announce our new relationship with Scottrade, a leading financial services firm.

Continue Reading →

David Trainer on CNBC’s Closing Bell: Nike vs. Under Armour


New Constructs CEO David Trainer appeared on CNBC’s Closing Bell on Wednesday June 1, 2016 to discuss Nike (NKE) vs. Under Amour (UA) and which provides the better risk/reward.

Continue Reading →

CNBC Features Non-GAAP Expert


New Constructs CEO David Trainer appeared on CNBC’s Santelli Exchange on Wednesday May 25, 2016 to discuss the credibility of non-GAAP earnings and its damaging effects on shareholders.

Continue Reading →

“Valeant Doesn’t Look Cheap” – Barron’s


Over the weekend, Barron’s magazine featured our research for the fourth time in 2016 and 20th time since 2014. This time, Barron’s featured our research on Valeant Pharmaceuticals (VRX).

Continue Reading →

FinTech: Disruptive Tech To Parse SEC Filings & Build Valuation Models Webinar


In this webinar, CEO David Trainer, will discuss our propriety research system, what makes us better, and how we can help protect investors, directors, and auditors.

Continue Reading →

#1 Ranked Stock Picker By SumZero


We are proud to announce that New Constructs has been ranked the #1 LTM Analyst per SumZero Rankings.

Continue Reading →

SumZero Features New Constructs Research


On Tuesday (3/15/16) SumZero prominently featured our research on Valeant Pharmaceuticals (VRX) as the stock dropped over 50% in one day

Continue Reading →

Page 1 of 2